LEARN MORE

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.

LEARN MORE

Events

Antiepileptic Drugs & Device Trials

5/17/17 - 5/19/17 | Aventura, FL

CDKL5 Congress

6/2/17 - 6/3/17 | Rome

Jefferies Global Healthcare Conference

6/6/17 - 6/9/17

More Events >

Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >